Neuren Pharmaceuticals Ltd (NURPF)
13.91
+0.35
(+2.58%)
USD |
OTCM |
May 22, 16:00
Neuren Pharmaceuticals Total Assets (Quarterly): 168.94M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 168.94M |
| June 30, 2023 | 64.55M |
| December 31, 2022 | 29.43M |
| June 30, 2022 | 23.79M |
| December 31, 2021 | 29.04M |
| June 30, 2021 | 14.27M |
| December 31, 2020 | 19.19M |
| June 30, 2020 | 6.661M |
| December 31, 2019 | 10.09M |
| June 30, 2019 | 12.68M |
| December 31, 2018 | 18.77M |
| June 30, 2018 | 13.82M |
| December 31, 2017 | 14.00M |
| June 30, 2017 | 1.189M |
| December 31, 2016 | 4.492M |
| June 30, 2016 | 6.888M |
| December 31, 2015 | 12.31M |
| June 30, 2015 | 14.36M |
| Date | Value |
|---|---|
| December 31, 2014 | 18.09M |
| June 30, 2014 | 22.29M |
| December 31, 2013 | 23.56M |
| June 30, 2013 | 6.414M |
| December 31, 2012 | 8.812M |
| June 30, 2012 | 11.28M |
| December 31, 2011 | 11.29M |
| June 30, 2011 | 7.126M |
| December 31, 2010 | 5.806M |
| June 30, 2010 | 6.912M |
| December 31, 2009 | 9.231M |
| June 30, 2009 | 5.221M |
| December 31, 2008 | 6.024M |
| June 30, 2008 | 13.36M |
| June 30, 2007 | 11.35M |
| June 30, 2006 | 12.57M |
| December 31, 2005 | 25.82M |
| June 30, 2005 | 16.24M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.661M
Minimum
Jun 2020
168.94M
Maximum
Dec 2023
37.86M
Average
21.49M
Median
Total Assets (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | 28.76M |
| Kazia Therapeutics Ltd | 16.61M |
| Immutep Ltd | 32.02M |
| Opthea Ltd | 166.50M |
| Mesoblast Ltd | 669.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.13M |
| Shareholders Equity (Quarterly) | 139.81M |
| Current Ratio | 5.780 |